Combined transcatheter aortic valve replacement and left atrial appendage occlusion in patients ineligible for oral anticoagulation: A case series
Patients presenting with aortic stenosis and atrial fibrillation (AF) undergoing transcatheter aortic valve replacement (TAVR) are commonly at increased risk for stroke and bleeding complications. Concomitant left atrial appendage occlusion (LAAO) after TAVR may be an alternative to oral anticoagula...
Saved in:
Published in | Journal of cardiology cases Vol. 26; no. 3; pp. 181 - 185 |
---|---|
Main Authors | , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Elsevier Ltd
01.09.2022
Japanese College of Cardiology |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Patients presenting with aortic stenosis and atrial fibrillation (AF) undergoing transcatheter aortic valve replacement (TAVR) are commonly at increased risk for stroke and bleeding complications. Concomitant left atrial appendage occlusion (LAAO) after TAVR may be an alternative to oral anticoagulation (OAC).
Between 2018 and 2022, 7 consecutive patients who were ineligible for OAC underwent simultaneous TAVR and LAAO. The mean age was 84.9 ± 4.9 years. The mean CHA2DS2-VASc, HAS-BLED, and STS predicted risk of mortality scores were 5.9 ± 0.7, 3.9 ± 1.1, and 8.8 ± 3.4%, respectively. The median follow-up time was 23 (1 to 27) months. All procedures achieved technical success and no adverse events were observed during follow-up. This case series shows that concomitant TAVR and LAAO is feasible and safe among patients with severe aortic stenosis and AF who are deemed ineligible for OAC.
Atrial fibrillation is the most common arrhythmia in the transcatheter aortic valve replacement (TAVR) population. In those who experience major or life-threatening bleeding, mortality is doubled. We report a case series of 7 concomitant left atrial appendage occlusions (LAAO) after TAVR in patients ineligible for oral anticoagulation. All procedures achieved technical success and no adverse events were observed. The simultaneous approach with TAVR and LAAO was feasible and safe in this case series. |
---|---|
AbstractList | Patients presenting with aortic stenosis and atrial fibrillation (AF) undergoing transcatheter aortic valve replacement (TAVR) are commonly at increased risk for stroke and bleeding complications. Concomitant left atrial appendage occlusion (LAAO) after TAVR may be an alternative to oral anticoagulation (OAC).
Between 2018 and 2022, 7 consecutive patients who were ineligible for OAC underwent simultaneous TAVR and LAAO. The mean age was 84.9 ± 4.9 years. The mean CHA2DS2-VASc, HAS-BLED, and STS predicted risk of mortality scores were 5.9 ± 0.7, 3.9 ± 1.1, and 8.8 ± 3.4%, respectively. The median follow-up time was 23 (1 to 27) months. All procedures achieved technical success and no adverse events were observed during follow-up. This case series shows that concomitant TAVR and LAAO is feasible and safe among patients with severe aortic stenosis and AF who are deemed ineligible for OAC.
Atrial fibrillation is the most common arrhythmia in the transcatheter aortic valve replacement (TAVR) population. In those who experience major or life-threatening bleeding, mortality is doubled. We report a case series of 7 concomitant left atrial appendage occlusions (LAAO) after TAVR in patients ineligible for oral anticoagulation. All procedures achieved technical success and no adverse events were observed. The simultaneous approach with TAVR and LAAO was feasible and safe in this case series. |
Author | Filho, Roberto Kalil e Silva, Ricardo Cavalcante Bignoto, Tiago Costa Abizaid, Alexandre de Brito, Fábio S. de Brito, Pedro Henrique Ferro Nicz, Pedro Felipe Gomes Melo, Pedro Henrique Magalhães Craveiro de Filippini, Filippe Barcellos Procópio, Arthur Guilherme Magalhães Ribeiro, Henrique Barbosa Freire, Antônio Fernando Diniz Grube, Eberhard Queiroga, Marcelo Bezerra, Cristiano Guedes |
Author_xml | – sequence: 1 givenname: Antônio Fernando Diniz surname: Freire fullname: Freire, Antônio Fernando Diniz organization: The Heart Institute, University of São Paulo Medical School, São Paulo, Brazil – sequence: 2 givenname: Filippe Barcellos surname: Filippini fullname: Filippini, Filippe Barcellos organization: The Heart Institute, University of São Paulo Medical School, São Paulo, Brazil – sequence: 3 givenname: Tiago Costa surname: Bignoto fullname: Bignoto, Tiago Costa organization: The Heart Institute, University of São Paulo Medical School, São Paulo, Brazil – sequence: 4 givenname: Pedro Henrique Ferro surname: de Brito fullname: de Brito, Pedro Henrique Ferro organization: Hospital Sírio-Libanês, São Paulo, Brazil – sequence: 5 givenname: Pedro Felipe Gomes surname: Nicz fullname: Nicz, Pedro Felipe Gomes organization: The Heart Institute, University of São Paulo Medical School, São Paulo, Brazil – sequence: 6 givenname: Pedro Henrique Magalhães Craveiro de surname: Melo fullname: Melo, Pedro Henrique Magalhães Craveiro de organization: Hospital Sírio-Libanês, São Paulo, Brazil – sequence: 7 givenname: Ricardo Cavalcante surname: e Silva fullname: e Silva, Ricardo Cavalcante organization: Hospital Sírio-Libanês, São Paulo, Brazil – sequence: 8 givenname: Marcelo surname: Queiroga fullname: Queiroga, Marcelo organization: Hospital Nossa Senhora das Neves, João Pessoa, Brazil – sequence: 9 givenname: Henrique Barbosa surname: Ribeiro fullname: Ribeiro, Henrique Barbosa organization: The Heart Institute, University of São Paulo Medical School, São Paulo, Brazil – sequence: 10 givenname: Arthur Guilherme Magalhães surname: Procópio fullname: Procópio, Arthur Guilherme Magalhães organization: Hospital Unimed Recife, Recife, Brazil – sequence: 11 givenname: Cristiano Guedes surname: Bezerra fullname: Bezerra, Cristiano Guedes organization: Hospital Aliança, Salvador, Brazil – sequence: 12 givenname: Eberhard surname: Grube fullname: Grube, Eberhard organization: The Heart Institute, University of São Paulo Medical School, São Paulo, Brazil – sequence: 13 givenname: Alexandre surname: Abizaid fullname: Abizaid, Alexandre organization: The Heart Institute, University of São Paulo Medical School, São Paulo, Brazil – sequence: 14 givenname: Roberto Kalil surname: Filho fullname: Filho, Roberto Kalil organization: The Heart Institute, University of São Paulo Medical School, São Paulo, Brazil – sequence: 15 givenname: Fábio S. surname: de Brito fullname: de Brito, Fábio S. email: fabio.cardiol@gmail.com organization: The Heart Institute, University of São Paulo Medical School, São Paulo, Brazil |
BookMark | eNp9kc2KHCEQxyVsyG42-wY5-ALT0dZ27RwCy5AvWMglOUup5ayDo432DOQ18sRxmJCPS-pSf7DqV1X-X5KrXDIS8pqzgTOu3uyHvXPQcBjZOA5MDozpZ-SG63u9mSSbr_7S1-SutT3rIbjUk35BroViM1dc3JAf23KwMaOna4XcHKxPuGKlUOoaHT1BOiGtuCRweMC8UsieJgxdrDVCorAsmD3skBbn0rHFkmnMdIE19vLWNaa4izYhDaXSUs89ubML7I6pV5X8lj7Q8zG0YY3YXpHnAVLDu1_5lnz78P7r9tPm8cvHz9uHx40TUumNUD5oxRlopueJT2OwoFCDZ1LCPCph7WxxVNzKoLkAF0ZtBVNzAIGT1-KWvLtwl6M9oHd93b6cWWo8QP1uCkTz70uOT2ZXTmaWcr4XqgPkBeBqaa1i-N3LmTnbZPbmYpM522SYNN2mP3OxH3eKWE1z_a8c-ljRrcaX-H_AT5MWojI |
CitedBy_id | crossref_primary_10_3390_jcdd10070279 |
Cites_doi | 10.1016/j.jacc.2014.04.029 10.4244/EIJY19M08_01 10.1016/j.jacc.2013.03.035 10.1016/j.hrthm.2017.05.038 10.4244/EIJV7I11A213 10.1056/NEJMoa2017815 10.1056/NEJMoa1911425 10.1016/j.jcin.2016.04.038 10.1016/j.jcin.2017.04.014 |
ContentType | Journal Article |
Copyright | 2022 Elsevier Ltd 2022 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved. All rights reserved. 2022 Elsevier Ltd |
Copyright_xml | – notice: 2022 Elsevier Ltd – notice: 2022 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved. All rights reserved. 2022 Elsevier Ltd |
DBID | AAYXX CITATION 5PM |
DOI | 10.1016/j.jccase.2022.04.008 |
DatabaseName | CrossRef PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef |
DatabaseTitleList | |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1878-5409 |
EndPage | 185 |
ExternalDocumentID | 10_1016_j_jccase_2022_04_008 S1878540922000780 |
GroupedDBID | --- --K --M -RU .1- .FO .~1 0R~ 1B1 1P~ 1~. 1~5 457 4G. 53G 5VS 6I. 7-5 71M 8P~ AACTN AAEDT AAEDW AAFTH AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AAXUO ABBQC ABLVK ABMAC ABMZM ABVKL ABXDB ABYKQ ACDAQ ACGFS ACRLP ADBBV ADEZE AEBSH AEKER AEVXI AEXQZ AFCTW AFKWA AFRHN AFTJW AFXIZ AGHFR AGUBO AGYEJ AIEXJ AIKHN AITUG AJBFU AJOXV AJRQY AJUYK ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX AOIJS AXJTR BKOJK BLXMC BNPGV EBS EFJIC EFLBG EJD EP3 FDB FEDTE FIRID FNPLU FYGXN GBLVA HVGLF HYE HZ~ IXB J1W KOM LCYCR M41 MO0 N9A NCXOZ O-L O9- OAUVE OA~ OK1 OL0 OZT P-8 P-9 PC. Q38 RIG ROL RPM SDF SEL SES SPCBC SSH SSZ T5K Z5R ~G- 0SF AAXKI AAYXX ADVLN AKRWK CITATION 5PM |
ID | FETCH-LOGICAL-c3468-36df8610a80895152fba6e8ad044a9263bb9be261b4f813acf28b3069fa3e5d83 |
IEDL.DBID | RPM |
ISSN | 1878-5409 |
IngestDate | Tue Sep 17 21:19:15 EDT 2024 Thu Sep 12 18:10:32 EDT 2024 Fri Feb 23 02:38:54 EST 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | Antiplatelet Valve replacement Atrial fibrillation Thrombus Stenosis Anticoagulation Aortic valve |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3468-36df8610a80895152fba6e8ad044a9263bb9be261b4f813acf28b3069fa3e5d83 |
OpenAccessLink | https://doi.org/10.1016/j.jccase.2022.04.008 |
PMID | 36091613 |
PageCount | 5 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_9449736 crossref_primary_10_1016_j_jccase_2022_04_008 elsevier_sciencedirect_doi_10_1016_j_jccase_2022_04_008 |
PublicationCentury | 2000 |
PublicationDate | 2022-09-01 |
PublicationDateYYYYMMDD | 2022-09-01 |
PublicationDate_xml | – month: 09 year: 2022 text: 2022-09-01 day: 01 |
PublicationDecade | 2020 |
PublicationTitle | Journal of cardiology cases |
PublicationYear | 2022 |
Publisher | Elsevier Ltd Japanese College of Cardiology |
Publisher_xml | – name: Elsevier Ltd – name: Japanese College of Cardiology |
References | Holmes, Kar, Price, Whisenant, Sievert, Doshi (bb0015) 2014; 64 Bogunovic, Scholtz, Prinz, Faber, Horstkotte, van Buuren (bb0025) 2012; 7 Reddy, Mobius-Winkler, Miller, Neuzil, Schuler, Wiebe (bb0050) 2013; 61 Attinger-Toller, Maisano, Senn, Taramasso, Shakir, Possner (bb0010) 2016; 9 Tarantini, Mojoli, Urena, Vahanian (bb0005) 2017; 38 Dangas, Tijssen, Wöhrle, Søndergaard, Gilard, Möllmann (bb0040) 2020; 382 Boersma, Ince, Kische, Pokushalov, Schmitz, Schmidt (bb0045) 2017; 14 Rodes-Cabau, Masson, Welsh, Del Blanco, Pelletier, Webb (bb0035) 2017; 10 Brouwer, Nijenhuis, Delewi, Hermanides, Holvoet, Dubois (bb0030) 2020; 383 Glikson, Wolff, Hindricks, Mandrola, Camm, Lip (bb0020) 2020; 15 Glikson (10.1016/j.jccase.2022.04.008_bb0020) 2020; 15 Brouwer (10.1016/j.jccase.2022.04.008_bb0030) 2020; 383 Holmes (10.1016/j.jccase.2022.04.008_bb0015) 2014; 64 Dangas (10.1016/j.jccase.2022.04.008_bb0040) 2020; 382 Tarantini (10.1016/j.jccase.2022.04.008_bb0005) 2017; 38 Attinger-Toller (10.1016/j.jccase.2022.04.008_bb0010) 2016; 9 Bogunovic (10.1016/j.jccase.2022.04.008_bb0025) 2012; 7 Rodes-Cabau (10.1016/j.jccase.2022.04.008_bb0035) 2017; 10 Reddy (10.1016/j.jccase.2022.04.008_bb0050) 2013; 61 Boersma (10.1016/j.jccase.2022.04.008_bb0045) 2017; 14 |
References_xml | – volume: 14 start-page: 1302 year: 2017 end-page: 1308 ident: bb0045 article-title: Efficacy and safety of left atrial appendage closure with WATCHMAN in patients with or without contraindication to oral anticoagulation: 1-year follow-up outcome data of the EWOLUTION trial publication-title: Heart Rhythm contributor: fullname: Schmidt – volume: 64 start-page: 1 year: 2014 end-page: 12 ident: bb0015 article-title: Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial publication-title: J Am Coll Cardiol contributor: fullname: Doshi – volume: 383 start-page: 1447 year: 2020 end-page: 1457 ident: bb0030 article-title: Aspirin with or without clopidogrel after transcatheter aortic-valve implantation publication-title: N Engl J Med contributor: fullname: Dubois – volume: 9 start-page: 1487 year: 2016 end-page: 1495 ident: bb0010 article-title: “One-Stop Shop”: safety of combining transcatheter aortic valve replacement and left atrial appendage occlusion publication-title: JACC Cardiovasc Interv contributor: fullname: Possner – volume: 10 start-page: 1357 year: 2017 end-page: 1365 ident: bb0035 article-title: Aspirin versus aspirin plus clopidogrel as antithrombotic treatment following transcatheter aortic valve replacement with a balloon-expandable valve: the ARTE (Aspirin Versus Aspirin + Clopidogrel Following Transcatheter Aortic Valve Implantation) randomized clinical trial publication-title: JACC Cardiovasc Interv contributor: fullname: Webb – volume: 382 start-page: 120 year: 2020 end-page: 129 ident: bb0040 article-title: A controlled trial of rivaroxaban after transcatheter aortic-valve replacement publication-title: N Engl J Med contributor: fullname: Möllmann – volume: 61 start-page: 2551 year: 2013 end-page: 2556 ident: bb0050 article-title: Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology) publication-title: J Am Coll Cardiol contributor: fullname: Wiebe – volume: 38 start-page: 1285 year: 2017 end-page: 1293 ident: bb0005 article-title: Atrial fibrillation in patients undergoing transcatheter aortic valve implantation: epidemiology, timing, predictors, and outcome publication-title: Eur Heart J contributor: fullname: Vahanian – volume: 7 start-page: 1361 year: 2012 end-page: 1363 ident: bb0025 article-title: Percutaneous closure of left atrial appendage after transcatheter aortic valve implantation - an interventional approach to avoid anticoagulation therapy in elderly patients: TAVI and closure of LAA to avoid warfarin therapy publication-title: EuroIntervention contributor: fullname: van Buuren – volume: 15 start-page: 1133 year: 2020 end-page: 1180 ident: bb0020 article-title: EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion – an update publication-title: EuroIntervention contributor: fullname: Lip – volume: 64 start-page: 1 year: 2014 ident: 10.1016/j.jccase.2022.04.008_bb0015 article-title: Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2014.04.029 contributor: fullname: Holmes – volume: 15 start-page: 1133 year: 2020 ident: 10.1016/j.jccase.2022.04.008_bb0020 article-title: EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion – an update publication-title: EuroIntervention doi: 10.4244/EIJY19M08_01 contributor: fullname: Glikson – volume: 61 start-page: 2551 year: 2013 ident: 10.1016/j.jccase.2022.04.008_bb0050 article-title: Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology) publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2013.03.035 contributor: fullname: Reddy – volume: 38 start-page: 1285 year: 2017 ident: 10.1016/j.jccase.2022.04.008_bb0005 article-title: Atrial fibrillation in patients undergoing transcatheter aortic valve implantation: epidemiology, timing, predictors, and outcome publication-title: Eur Heart J contributor: fullname: Tarantini – volume: 14 start-page: 1302 year: 2017 ident: 10.1016/j.jccase.2022.04.008_bb0045 article-title: Efficacy and safety of left atrial appendage closure with WATCHMAN in patients with or without contraindication to oral anticoagulation: 1-year follow-up outcome data of the EWOLUTION trial publication-title: Heart Rhythm doi: 10.1016/j.hrthm.2017.05.038 contributor: fullname: Boersma – volume: 7 start-page: 1361 year: 2012 ident: 10.1016/j.jccase.2022.04.008_bb0025 article-title: Percutaneous closure of left atrial appendage after transcatheter aortic valve implantation - an interventional approach to avoid anticoagulation therapy in elderly patients: TAVI and closure of LAA to avoid warfarin therapy publication-title: EuroIntervention doi: 10.4244/EIJV7I11A213 contributor: fullname: Bogunovic – volume: 383 start-page: 1447 year: 2020 ident: 10.1016/j.jccase.2022.04.008_bb0030 article-title: Aspirin with or without clopidogrel after transcatheter aortic-valve implantation publication-title: N Engl J Med doi: 10.1056/NEJMoa2017815 contributor: fullname: Brouwer – volume: 382 start-page: 120 year: 2020 ident: 10.1016/j.jccase.2022.04.008_bb0040 article-title: A controlled trial of rivaroxaban after transcatheter aortic-valve replacement publication-title: N Engl J Med doi: 10.1056/NEJMoa1911425 contributor: fullname: Dangas – volume: 9 start-page: 1487 year: 2016 ident: 10.1016/j.jccase.2022.04.008_bb0010 article-title: “One-Stop Shop”: safety of combining transcatheter aortic valve replacement and left atrial appendage occlusion publication-title: JACC Cardiovasc Interv doi: 10.1016/j.jcin.2016.04.038 contributor: fullname: Attinger-Toller – volume: 10 start-page: 1357 year: 2017 ident: 10.1016/j.jccase.2022.04.008_bb0035 publication-title: JACC Cardiovasc Interv doi: 10.1016/j.jcin.2017.04.014 contributor: fullname: Rodes-Cabau |
SSID | ssj0000314858 |
Score | 2.2589707 |
Snippet | Patients presenting with aortic stenosis and atrial fibrillation (AF) undergoing transcatheter aortic valve replacement (TAVR) are commonly at increased risk... |
SourceID | pubmedcentral crossref elsevier |
SourceType | Open Access Repository Aggregation Database Publisher |
StartPage | 181 |
SubjectTerms | Anticoagulation Antiplatelet Aortic valve Atrial fibrillation Case Report Stenosis Thrombus Valve replacement |
SummonAdditionalLinks | – databaseName: ScienceDirect Free and Delayed Access Titles dbid: IXB link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8QwEA7iQbyIT3wzB69lt0m2TbypKCLoRYW9laSd6MrSXdxdf4i_2Jm0FRcEwVvbtE2bmWZm0m--EeIsVaW0LtOJ0ZICFK_ShKxgmrCpTPOMDFgZAbIP2e2zvhsOhiviqsuFYVhlO_c3c3qcrdsjvXY0e9PRqPeYmtyQv2GljIaO43bm9uQkvuHl9zoL07ObWKaTz2ccgO0y6CLM641eYcZ8mVJGzlOuM_m7hVoGTf6wQjebYqN1H-GiecItsYL1tli7b3-Q74hP-r4p1sUK5myEIikrjRy4CV8BpFYfCO8YkVi8LgiurmCMgTZi_Q5wUy6KS5MMTMpyvOC1NBjV0NKvzmg7Ypj9GIHcXeD8froH3XviXtpKYOdwAfy2wNqNs13xfHP9dHWbtGUXklJxHpbKqmDIq3Kmb8j_GsjgXYbGVX2tnZWZ8t56pMjL62BS5cogjafIwwancFAZtSdW60mN-wLyUDkM1GAQtUlTa0OFzAkXDPqgBwci6Ya6mDbsGkUHO3srGtEULJqirwsSzYHIO3kUS1pSkAH468ol8X13x_Tayy316DXSbFutba6yw3_3eSTWea9BpB2L1fn7Ak_IhZn706ijX7oU84Q priority: 102 providerName: Elsevier |
Title | Combined transcatheter aortic valve replacement and left atrial appendage occlusion in patients ineligible for oral anticoagulation: A case series |
URI | https://dx.doi.org/10.1016/j.jccase.2022.04.008 https://pubmed.ncbi.nlm.nih.gov/PMC9449736 |
Volume | 26 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fb9MwED6tQ0K8IH6KbVDdA69pm9hJnL11E1PH2MQDQ32L7OQMnbq0Wjse-SP4i7lzErRKSEg8xYplx_Fd_N05n-8A3seqSgqb6cjohB0Up-KIUTCOBCrjPGMAqwJB9iqbXeuP83S-B2l_FiaQ9iu3GDXL21Gz-B64levbatzzxMafL08LrYtcZeMBDHKlHrjoYflVbOGnpj8mF7hcNzzOjQTFTJIQ2HQiafpUxlgZ8hr8HZF2SZIPUOfsGTztzEWctsN6DnvUvIDHl90P8Zfwi79n9m2pxq2ATgjCyjOFdiUtkNXoB-EdBeaV7AOibWpckudCyNeBdi1JcHlRwVVVLe9l7wwXDXbhVjdcDpxltyRk8xblPD_3wX2v7Lcu89cxTlFeHEWbafMKrs8-fDmdRV2ahahScu5KZbU3bEVZMzFsb6WJdzYjY-uJ1rZIMuVc4Yg9Lae9iZWtfGIcexqFt4rS2qjXsN-sGnoDmPvakucKQ6RNHBeFr0liwHlDzuv0AKJ-qst1G02j7GlmN2UrpVKkVE50yVI6gLyXR9lZBC3Sl7zg_6vljvj-PE7Cae_WsJaFsNqdVh3-d8sjeCIjaBlob2F_e3dP79hk2bohDEY_4yE8mp58vfgk1_OL2RXfPZ-fDIP6_gbTZvYh |
link.rule.ids | 230,315,733,786,790,891,3525,4521,24144,27602,27957,27958,45620,45698,45714,45909,53827,53829 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3BTtwwELUQlUovVWlBpS3tHHqNdmM7ic2NoqKFApeCtDfLTsZ00Sq7Ypd-SL-YGSdBXQmpUm9WLNuxZ-KZcZ7fCPE1V7W0vtSZ0ZIClKDyjKxgnrGpzKuSDFidALJX5eRGn0-L6ZY4Ge7CMKyy3_u7PT3t1v2TUb-ao-VsNvqZm8qQv2GlTIaO4vYXurBjVu2z6bengxbmZzcpTyc3YCCAHa7QJZzXHc1hxYSZUibSU040-byJ2kRN_mWGTt-I173_CMfdK-6KLWzfipeX_R_yd-IPfeAU7GIDa7ZCiZWVlg78glsA6dVvhHtMUCw-GATfNjDHSIWUwAP8krPi0i4Di7qeP_BhGsxa6PlXV1ROIOYwRyB_F_iCP_VBfS_8bZ8K7AiOgWcLrN642hM3p9-vTyZZn3chqxVfxFJlEw25Vd6MDTlghYzBl2h8M9baW1mqEGxACr2CjiZXvo7SBAo9bPQKi8aofbHdLlp8L6CKjcdIFQZRmzy3NjbIpHDRYIi6OBDZsNRu2dFruAF3duc60TgWjRtrR6I5ENUgD7ehJo4swL9abojvaTjm196saWe_Es-21dpWqvzw32N-ETuT68sLd3F29eOjeMU1HTztk9he3z_gIfkz6_A56esjDbX2qw |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1NT9wwELUKlRCX0i8EpR9z4JrdTexkbW4IWNEWEIcioV4s2xm3uyzZFbvLgZ_BL-7YSardqhISt0iJHScz9ptJnt8wtp9ylylTiESKjBIUy9OEUDBNAlSm_YIAzEWC7EVxeiW-XefXS6W-Imnf2WGnGt92quHvyK2c3rpuyxPrXp4fKSFUnxfdaem7a-wlzdlMLSXqcRHmFOfnst0sFxldIxrtLEhjZlmUN-2FYn28IMSM1Q3-j0urVMkl7BlssZ_tqGvKyU1nMbcd9_CPoOOzHus1e9VEpHBYX_KGvcDqLds4b_65v2OPtGRQ-owlzAOuRZ1XMgaYSWgB5Kn3CHcYyV3hUyOYqoQxejqIJUHATEOdXVq3YOLceBE-z8GwgkbRdUbHkRZtxwgUQUOQDKA-qO-J-dUUFzuAQwhvFcKEwdl7djU4-XF0mjSVHBLHw9YuXpReUqBmZE9SSJdn3poCpSl7QhiVFdxaZZGSOSu8TLlxPpOWkhnlDce8lHybrVeTCncY9H1p0NMJiShkmirlSwwyc16i9SLfZUlrRz2tBTt0y2Qb6doFdHAB3ROaXGCX9Vtj6yboqIMJTZjyVMsV3_h7u6DYvXqGLB6VuxsLf3h2yy9s4_J4oM--XnzfY5thMDXf7SNbn98t8BMFSHP7OU6FP_i0FY8 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Combined+transcatheter+aortic+valve+replacement+and+left+atrial+appendage+occlusion+in+patients+ineligible+for+oral+anticoagulation%3A+A+case+series&rft.jtitle=Journal+of+cardiology+cases&rft.au=Freire%2C+Ant%C3%B4nio+Fernando+Diniz&rft.au=Filippini%2C+Filippe+Barcellos&rft.au=Bignoto%2C+Tiago+Costa&rft.au=de+Brito%2C+Pedro+Henrique+Ferro&rft.date=2022-09-01&rft.pub=Elsevier+Ltd&rft.issn=1878-5409&rft.eissn=1878-5409&rft.volume=26&rft.issue=3&rft.spage=181&rft.epage=185&rft_id=info:doi/10.1016%2Fj.jccase.2022.04.008&rft.externalDocID=S1878540922000780 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1878-5409&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1878-5409&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1878-5409&client=summon |